PHI Medical Aesthetics

PHI Medical Aesthetics, based in Calgary, Canada, specializes in aesthetic treatments that enhance natural beauty, including injectables like lip fillers and Botox, contributing to clients' confidence and youthful appearances. Founded in 2018 and headquartered in Calgary, Canada, PHI Medical Aesthetics focuses on aesthetic services. With 1 recorded deal, the company has remained consistent in its operational focus without any significant pivots. The founder's background details are not publicly available.

PHI Medical Aesthetics specializes in aesthetic treatments aimed at enhancing and restoring natural beauty. Their primary offerings include injectable treatments such as lip fillers, Botox for wrinkle reduction, and Belkyra for facial contouring, all aimed at managing the aging process and promoting self-confidence. The company operates injectables-only clinics, leveraging decades of expertise in medical aesthetics to deliver high-quality results, primarily targeting clients in urban areas like Calgary and its surroundings. PHI Medical Aesthetics generates revenue through direct consumer transactions for its aesthetic services.

Clients typically book appointments for treatments, with prices structured on a per-session basis. This model encourages direct interactions with clients, utilizing only high-quality medical-grade skincare products to enhance the overall treatment experience and foster client loyalty. In January 2026, PHI Medical Aesthetics was acquired by Victoria Park Medispa, a portfolio company of Peloton Capital Management, with undisclosed financial terms. This acquisition is expected to help expand Victoria Park Medispa's customer base.

Upcoming plans may include the development and launch of new aesthetic products, along with potential expansion into additional Canadian markets beyond Calgary.